Zoledronic acid inhibits the development of osteolytic bone disease and increases disease free survival in a murine model of multiple myeloma
Year: 2001
Type: article
Authors: Peter I. Croucher, Anja Hijzen, C M Shipman, Mark Perry, J M Lippitt, J Green, B Van Camp, Karin Vanderkerken
Language: English
Topic: Bone health and treatments
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2461396111
